BPC-157 and Histamine Flushing: Supplements With the Best Evidence

Does BPC-157 Cause Histamine Flushing?

No clinical study or adverse-event report in FDA's review documents flushing with BPC-157. FDA searched its adverse-event database through December 4, 2025 and found three reports, all for injectable BPC-157: injection-site redness and swelling for 9 days, shortness of breath leading to an emergency room visit, and widespread skin and gum darkening that recurred on re-exposure to a BPC-157 plus TB-500 product. FDA said it cannot tell whether BPC-157 caused any of them [5].

Could Mast Cells Be Involved?

Some peptides can activate mast cells without IgE through a receptor called MRGPRX2, which is found on mast cells and is activated by host-defense peptides and several approved peptidergic drugs [6]. Whether BPC-157 does this is unknown: FDA states that its molecular targets have not been identified and its mechanisms remain poorly understood [5].

What the Supplement Evidence Shows

Quercetin

In cultured human mast cells, quercetin inhibited release of histamine, leukotrienes, prostaglandin D2 and GM-CSF in a concentration-dependent way and inhibited calcium influx and PKC translocation [1]. At 100 micromolar it inhibited histamine and prostaglandin D2 secretion from cultured human mast cells and was more effective than cromolyn at blocking IL-8 and TNF release from a mast-cell line; the authors said formulations allowing better oral absorption are needed [2]. The outcome measured was mediator release, not flushing.

Diamine oxidase (DAO)

DAO is the main enzyme for metabolising ingested histamine, and people with low amine oxidase activity are at risk of histamine toxicity from histamine-rich food, with flushing among the listed symptoms [7]. A retrospective review of 14 patients with food-triggered symptoms found 10 of 14 had serum DAO below 10 U/mL, a group mean of 7.04 U/mL against 39.50 U/mL in 34 healthy controls (P=0.0031), and 13 of 14 reporting benefit in at least one symptom after DAO supplements [3]. The supplement response had no control group, and the histamine came from food.

Vitamin C

Across 437 blood samples, whole blood histamine rose steeply as plasma reduced ascorbic acid fell below 1 mg/100 mL, and 11 volunteers who took 1 g of ascorbic acid daily for 3 days had lower blood histamine in every case [4]. The outcome was blood histamine, not flushing.

Regulatory Status of BPC-157

BPC-157 is not an FDA-approved drug; FDA's July 2026 review found no approved product containing it in any country it searched, and FDA says it has identified no, or only limited, safety-related information for the proposed routes of administration [5][8]. WADA names BPC-157 in class S0, prohibited at all times, in and out of competition [9].